Amryt Pharma Plc Overview

Amryt Pharma Plc Other Income Expense Net

Other Income/Expense Net for AMYT.

Quarterly Other Income/Expense

-$7.64M

↑ 66.19% YoY

As of Sep 30, 2022

Annual Other Income/Expense (TTM)

$20.47M

↑ 134.54% YoY

Trailing 12 months ending Sep 30, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin